Curanex Pharmaceuticals (CURX) Total Liabilities (2024 - 2026)

Curanex Pharmaceuticals (CURX) has reported Total Liabilities for 3 consecutive years, with $286254.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 40.58% year-over-year to $286254.0; the trailing twelve-month figure through Jun 2026 stood at $286254.0 (down 40.58% YoY), and the FY2025 full-year result was $361040.0, up 2377.12% from the prior year.
• Total Liabilities fell to $286254.0 in Q2 2026 per CURX's latest filing, from $361040.0 in the prior quarter.
• Across five years, Total Liabilities topped out at $481743.0 in Q2 2025 and bottomed at -$624165.0 in Q3 2024.
• Historically, Total Liabilities has averaged $117567.0 across 3 years, with a median of $236104.5 in 2025.
• The sharpest annual moves came in 2025 and 2026: Total Liabilities jumped 2377.12% in 2025, then tumbled 40.58% in 2026.
• Over 3 years, Total Liabilities stood at $14575.0 in 2024, then surged by 2377.12% to $361040.0 in 2025, then declined by 20.71% to $286254.0 in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $286254.0, $361040.0, and $185955.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.